in

Ireland, Netherlands become latest countries to suspend AstraZeneca vaccine over blood clot fears


A medical employee fills a syringe with AstraZeneca vaccine at Santa Caterina da Siena – Amendola secondary School in Salerno on March 13, 2021 in Salerno, Italy.

Francesco Pecoraro | Getty Images News | Getty Images

LONDON — Ireland and the Netherlands have joined the rising listing of countries which have suspended using the coronavirus vaccine developed by AstraZeneca and the University of Oxford over blood clot considerations.

The Dutch authorities stated on Sunday that the Oxford-AstraZeneca vaccine wouldn’t be used till not less than March 29, whereas Ireland stated earlier within the day that it had briefly suspended the shot as a precautionary step.

The World Health Organization has sought to downplay ongoing security considerations, saying final week that there isn’t a hyperlink between the shot and an elevated threat of creating blood clots. The United Nations well being company has urged countries to proceed utilizing the Oxford-AstraZeneca vaccine.

Despite this, quite a lot of European countries have already paused using the Oxford-AstraZeneca vaccine. It has added to the woes of the area’s ailing vaccination marketing campaign at a time when Germany’s public well being company has warned {that a} third wave of coronavirus infections has already begun.

Thailand has additionally halted its deliberate deployment of the vaccine.

The transfer to pause its use by Dutch and Irish officers got here shortly after Norway’s medicines company stated it had been notified of three well being staff being handled in hospital for bleeding, blood clots and a low rely of blood platelets after receiving the Oxford-AstraZeneca vaccine. Norway has put its Oxford-AstraZeneca vaccine program on maintain.

Geir Bukholm, director of the Division of Infection Control and Environmental Health on the Norwegian Institute of Public Health, stated Norway’s medicines company would “follow up on these suspected side effects and take the necessary measures in this serious situation.”

Picture taken on November 27, 2020 reveals “Nikki” Anniken Hars treating a Covid-19 affected person on the intensive care unit of Oslo University Hospital Rikshospitalet in Oslo, Norway.

JIL YNGLAND | AFP | Getty Images

Europe’s drug regulator, the European Medicines Agency, has additionally stated there isn’t a indication that the Oxford-AstraZeneca vaccine is inflicting blood clots, including that it believes the vaccine’s advantages “continue to outweigh its risks.”

The EMA acknowledged some European countries had paused using the Oxford-AstraZeneca shot however stated inoculations might proceed to be administered whereas an investigation of blood clot circumstances is ongoing.

How has AstraZeneca responded?

A well being employee holds a field of the AstraZeneneca vaccine on the Bamrasnaradura Infectious Diseases Institute in Nonthaburi province on the outskirts of Bangkok.

Chaiwat Subprasom | SOPA Images | LightRocket through Getty Images

The pharmaceutical big stated that throughout the EU and U.Okay. there had been 15 occasions of deep vein thrombosis and 22 occasions of pulmonary embolism reported amongst these vaccinated.

“This is much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed COVID-19 vaccines,” AstraZeneca stated.

What do the consultants say?



Source hyperlink

What do you think?

Written by Business Boy

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Kalyan Jewellers IPO: Price band, size and other important details for investors – Business News , Firstpost

Merkel’s party gets punished in state elections as Covid ‘third wave’ hits home